Neurophysiological markers in myelodysplastic syndromes: Insights into peripheral neuropathy

In their paper, Papantoniou et al. present relevant findings on the prevalence and characteristics of peripheral neuropathy in patients with myelodysplastic syndromes (MDS), underscoring the necessity for a more nuanced understanding of neurophysiological involvement in this complex haematological disorder. Their study not only reveals a higher frequency of neuropathy in MDS patients than previously reported but also illuminates specific neurophysiological patterns that may redefine clinical expectations and diagnostic practices in MDS-associated peripheral neuropathy. Commentary on: Papantoniou et al. Clinical and neurophysiological aspects of peripheral neuropathy in patients with myelodysplastic syndromes. Br J Haematol 2025; 206:864-867.